Publications

03-28 10:07
 
Functional changes in the oral microbiome after use of fluoride and arginine containing dentifrices: a metagenomic and metatranscriptomic study
03-28 10:07
 
Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey
03-28 10:07
 
A Dual Zinc plus Arginine formulation attenuates the pathogenic properties of Porphyromonas gingivalis and protects gingival keratinocyte barrier function in an in vitro model
03-28 10:07
 
Evaluating the impact of a novel behavioural science informed animation upon breast cancer screening uptake: protocol for a randomised controlled trial
03-28 10:07
 
Effect of platelet inhibition with cangrelor during PCI on ischemic events
03-28 10:07
 
The behaviour change wheel: a new method for characterising and designing behaviour change interventions
03-28 10:07
 
Text-message reminders increase uptake of routine breast screening appointments: a randomised controlled trial in a hard-to-reach population
03-28 10:07
 
Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial
03-28 10:07
 
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX
03-28 10:07
 
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention)
03-28 10:07
 
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)
03-28 10:07
 
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial
03-28 10:07
 
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial
03-28 10:07
 
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
03-28 10:07
 
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
03-28 10:07
 
Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials
03-28 10:07
 
Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial
03-28 10:07
 
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX
03-28 10:07
 
Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION
03-28 10:07
 
Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty
03-28 10:07
 
Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes
03-28 10:07
 
Testosterone and the aging male
03-28 10:07
 
Detection of changes in respiratory mechanics due to increasing degrees of airway obstruction in asthma by the forced oscillation technique
03-28 10:07
 
Clinical applications of forced oscillation techniques (FOT) in patients with bronchial asthma
03-28 10:07
 
Changes in respiratory mechanics with increasing degrees of airway obstruction in COPD: detection by forced oscillation technique

Clinical Research News

Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults
A new study of Dexpramipexole in adolescents and adults with severe Eosinophilic Asthma

Предстоящие клинические испытания

Clinical Research Jobs

All jobs

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться